Investing.com - Eli Lilly reported on Thursday fourth quarter earnings that beat analysts' forecasts and revenue that topped expectations.
Eli Lilly announced earnings per share of $1.73 on revenue of $6.11B. Analysts polled by Investing.com anticipated EPS of $1.52 on revenue of $5.91B. That with comparison to EPS of $1.33 on revenue of $6.44B in the same period a year before. Eli Lilly had reported EPS of $1.48 on revenue of $5.48B in the previous quarter. Analysts are expecting EPS of $1.47 and revenue of $5.53B in the upcoming quarter.
Eli Lilly shares are up 6.46% from the beginning of the year and are trading at $139.92 , still down 1.64% from its 52 week high of $142.25 set on January 22. They are outperforming the S&P 500 which is up 0.87% year to date.
Eli Lilly follows other major Healthcare sector earnings this month
Eli Lilly's report follows an earnings beat by J&J on January 22, who reported EPS of $1.88 on revenue of $20.75B, compared to forecasts EPS of $1.87 on revenue of $20.8B.
Novartis ADR had beat expectations on Wednesday with fourth quarter EPS of $1.32 on revenue of $12.4B, compared to forecast for EPS of $1.31 on revenue of $12.33B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar